http://orcid.org/0000-0002-7461-8829
References
- Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993;75:1027–1038.
- Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell. 1993;75:1215–1225.
- Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science. 1993;260:812–816.
- Li YC, Korol AB, Fahima T, et al. Microsatellites: genomic distribution, putative functions and mutational mechanisms: a review. Mol Ecol. 2002;11:2453–2465.
- Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin Cancer Res. 1998;4:1–6.
- Boland CR, Thibodeau SN, Hamilton SR, et al. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248–5257.
- Maehara Y, Oda S, Sugimachi K. The instability within: problems in current analyses of microsatellite instability. Mutat Res. 2001;461:249–263.
- Oda S, Oki E, Maehara Y, et al. Precise assessment of microsatellite instability using high resolution fluorescent microsatellite analysis. Nucleic Acids Res. 1997;25:3415–3420.
- Oda S, Maehara Y, Ikeda Y, et al. Two modes of microsatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability. Nucleic Acids Res. 2005;33:1628–1636.
- Miyashita K, Fujii K, Yamada Y, et al. Frequent microsatellite instability in non-Hodgkin lymphomas irresponsive to chemotherapy. Leuk Res. 2008;32:1183–1195.
- Fujii K, Miyashita K, Yamada Y, et al. Simulation-based analyses reveal stable microsatellite sequences in human pancreatic cancer. Cancer Genet Cytogenet. 2009;189:5–14.
- Gammie AE, Erdeniz N, Beaver J, et al. Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae. Genetics. 2007;177:707–721.
- Takahashi M, Shimodaira H, Andreutti-Zaugg C, et al. Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. Cancer Res. 2007;67:4595–4604.
- Oki E, Oda S, Maehara Y, et al. Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair. Oncogene. 1999;18:2143–2147.
- Velangi MR, Matheson EC, Morgan GJ, et al. DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma. Carcinogenesis. 2004;25:1795–1803.
- Nomdedéu JF, Lasa A, Ubeda J, et al. Interstitial deletions at the long arm of chromosome 13 may be as common as monosomies in multiple myeloma. A Genotypic Study. Haematologica. 2002;87:828–835.
- Timurağaoğlu A, Demircin S, Dizlek S, et al. Microsatellite instability is a common finding in multiple myeloma. Clin Lymphoma Myeloma. 2009;9:371–374.
- Cox EC. Bacterial mutator genes and the control of spontaneous mutation. Annu Rev Genet. 1976;10:135–156.
- Portier M, Moles JP, Mazars GR, et al. p53 and RAS gene mutations in multiple myeloma. Oncogene. 1992;7:2539–2543.
- Liu P, Leong T, Quam L, et al. Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial. Blood. 1996;88:2699–2706.
- Bezieau S, Devilder MC, Avet-Loiseau H, et al. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis. Hum Mutat. 2001;18:212–224.
- Fonseca R, Barlogie B, Bataille R, et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res. 2004;64:1546–1558.
- Branch P, Aquilina G, Bignami M, et al. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature. 1993;362:652–654.